Correction to: The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study

Robert W Koivula^{1

2}, Naeimeh Atabaki-Pasdar³, Giuseppe N Giordano³, Tom White⁴, Jerzy Adamski^{5

6

7}, Jimmy D Bell⁸, Joline Beulens⁹, Søren Brage^{4

10}, Søren Brunak^{11

12}, Federico De Masi^{11

12}, Emmanouil T Dermitzakis^{13

14

15}, Ian M Forgie¹⁶, Gary Frost¹⁷, Torben Hansen^{10

18}, Tue H Hansen¹⁸, Andrew Hattersley^{19

20}, Tarja Kokkola²¹, Azra Kurbasic³, Markku Laakso²¹, Andrea Mari²², Timothy J McDonald¹⁹, Oluf Pedersen¹⁸, Femke Rutters⁹, Jochen M Schwenk²³, Harriet J A Teare²⁴, E Louise Thomas⁸, Ana Vinuela^{13

14

15}, Anubha Mahajan²⁵, Mark I McCarthy^{26

25

27

28}, Hartmut Ruetten²⁹, Mark Walker³⁰, Ewan Pearson¹⁶, Imre Pavo³¹, Paul W Franks^{3

26

32

33}; IMI DIRECT Consortium

Affiliations

¹ Department of Clinical Sciences, Lund University, Genetic and Molecular Epidemiology, CRC, Skåne University Hospital Malmö, Building 91, Level 12, Jan Waldenströms gata 35, SE-205 02, Malmö, Sweden. robert.koivula@med.lu.se.
² Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. robert.koivula@med.lu.se.
³ Department of Clinical Sciences, Lund University, Genetic and Molecular Epidemiology, CRC, Skåne University Hospital Malmö, Building 91, Level 12, Jan Waldenströms gata 35, SE-205 02, Malmö, Sweden.
⁴ MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
⁵ Research Unit Molecular Endocrinology and Metabolism, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
⁶ Lehrstuhl für Experimentelle Genetik, Technische Universität München, Freising-Weihenstephan, Germany.
⁷ Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore.
⁸ Research Centre for Optimal Health, Department of Life Sciences, University of Westminister, London, UK.
⁹ Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam University Medical Centre, Location VU University Medical Center, Amsterdam, the Netherlands.
¹⁰ Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
¹¹ The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
¹² Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark.
¹³ Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
¹⁴ Institute of Genetics and Genomics in Geneva (iGE3), University of Geneva, Geneva, Switzerland.
¹⁵ Swiss Institute of Bioinformatics, Geneva, Switzerland.
¹⁶ Population Health & Genomics, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, UK.
¹⁷ Nutrition and Dietetics Research Group, Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Campus, London, UK.
¹⁸ The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
¹⁹ NIHR Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, UK.
²⁰ Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.
²¹ Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
²² Institute of Neurosciences, National Research Council, Padova, Italy.
²³ Affinity Proteomics, Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
²⁴ HeLEX, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, UK.
²⁵ Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
²⁶ Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
²⁷ NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK.
²⁸ Human Genetics, Genentech, South San Francisco, CA, USA.
²⁹ Sanofi-Aventis Deutschland GmbH, R&D, Frankfurt am Main, Germany.
³⁰ Institute of Cellular Medicine (Diabetes), Newcastle University, Newcastle upon Tyne, UK.
³¹ Eli Lilly Regional Operations GmbH, Vienna, Austria.
³² Department of Nutrition, Harvard School of Public Health, Boston, MA, USA.
³³ Department of Public Health & Clinical Medicine, Section for Medicine, Umeå University Hospital, Umeå, Sweden.

PMID: 33184701
PMCID: PMC7852866
DOI: 10.1007/s00125-020-05311-4

Published Erratum

Correction to: The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study

Robert W Koivula et al. Diabetologia. 2021 Jan.

. 2021 Jan;64(1):260-261.

doi: 10.1007/s00125-020-05311-4.

Authors

Affiliations

¹ Department of Clinical Sciences, Lund University, Genetic and Molecular Epidemiology, CRC, Skåne University Hospital Malmö, Building 91, Level 12, Jan Waldenströms gata 35, SE-205 02, Malmö, Sweden. robert.koivula@med.lu.se.
² Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. robert.koivula@med.lu.se.
³ Department of Clinical Sciences, Lund University, Genetic and Molecular Epidemiology, CRC, Skåne University Hospital Malmö, Building 91, Level 12, Jan Waldenströms gata 35, SE-205 02, Malmö, Sweden.
⁴ MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
⁵ Research Unit Molecular Endocrinology and Metabolism, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
⁶ Lehrstuhl für Experimentelle Genetik, Technische Universität München, Freising-Weihenstephan, Germany.
⁷ Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore.
⁸ Research Centre for Optimal Health, Department of Life Sciences, University of Westminister, London, UK.
⁹ Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam University Medical Centre, Location VU University Medical Center, Amsterdam, the Netherlands.
¹⁰ Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
¹¹ The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
¹² Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark.
¹³ Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
¹⁴ Institute of Genetics and Genomics in Geneva (iGE3), University of Geneva, Geneva, Switzerland.
¹⁵ Swiss Institute of Bioinformatics, Geneva, Switzerland.
¹⁶ Population Health & Genomics, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, UK.
¹⁷ Nutrition and Dietetics Research Group, Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Campus, London, UK.
¹⁸ The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
¹⁹ NIHR Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, UK.
²⁰ Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.
²¹ Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
²² Institute of Neurosciences, National Research Council, Padova, Italy.
²³ Affinity Proteomics, Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
²⁴ HeLEX, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, UK.
²⁵ Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
²⁶ Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
²⁷ NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK.
²⁸ Human Genetics, Genentech, South San Francisco, CA, USA.
²⁹ Sanofi-Aventis Deutschland GmbH, R&D, Frankfurt am Main, Germany.
³⁰ Institute of Cellular Medicine (Diabetes), Newcastle University, Newcastle upon Tyne, UK.
³¹ Eli Lilly Regional Operations GmbH, Vienna, Austria.
³² Department of Nutrition, Harvard School of Public Health, Boston, MA, USA.
³³ Department of Public Health & Clinical Medicine, Section for Medicine, Umeå University Hospital, Umeå, Sweden.

PMID: 33184701
PMCID: PMC7852866
DOI: 10.1007/s00125-020-05311-4

Abstract

Unfortunately, 'Present address' was omitted from one of the addresses provided for Mark I. McCarthy (#26).

PubMed Disclaimer

Erratum for

The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study.
Koivula RW, Atabaki-Pasdar N, Giordano GN, White T, Adamski J, Bell JD, Beulens J, Brage S, Brunak S, De Masi F, Dermitzakis ET, Forgie IM, Frost G, Hansen T, Hansen TH, Hattersley A, Kokkola T, Kurbasic A, Laakso M, Mari A, McDonald TJ, Pedersen O, Rutters F, Schwenk JM, Teare HJA, Thomas EL, Vinuela A, Mahajan A, McCarthy MI, Ruetten H, Walker M, Pearson E, Pavo I, Franks PW; IMI DIRECT Consortium. Koivula RW, et al. Diabetologia. 2020 Apr;63(4):744-756. doi: 10.1007/s00125-019-05083-6. Epub 2020 Jan 30. Diabetologia. 2020. PMID: 32002573 Free PMC article.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study

Affiliations

Correction to: The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study

Authors

Affiliations

Abstract

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources